Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)

South Korea · Delayed Price · Currency is KRW

141,500

+8,200 (6.15%)

At close: Feb 27, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
BNF Business	8.61B	31.72B	30.73B	26.65B	24.28B
BNF Business Growth	-72.85%	3.24%	15.28%	9.76%	36.56%
New Drug Business	-	-	-	-	4.35B
New Drug Business Growth	-	-	-	-	3050.15%
Total	8.61B	31.72B	30.73B	26.65B	28.63B
Total Growth	-72.85%	3.24%	15.28%	-6.92%	59.79%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
South Korea	8.61B	31.72B	30.73B	26.65B	24.28B
South Korea Growth	-72.85%	3.24%	15.28%	9.76%	36.56%
Russia	-	-	-	-	128.05M
Russia Growth	-	-	-	-	-7.27%
Hong Kong	-	-	-	-	4.22B
Total	8.61B	31.72B	30.73B	26.65B	28.63B
Total Growth	-72.85%	3.24%	15.28%	-6.92%	59.79%

Source: S&P Global Market Intelligence.